Looking for information on Kankan Airport, Kankan, Guinea? Know about Kankan Airport in detail. Find out the location of Kankan Airport on Guinea map and also find out airports near to Kankan. This ...

Wockhardt Ltd., incorporated in the year 1999, is a Mid Cap company (having a market cap of Rs 23,807.39 Crore) operating in Pharmaceuticals sector. Wockhardt Ltd. key Products/Revenue Segments ...

Wockhardt Limited incorporated in July 1999 is a global pharmaceutical and biotechnology organization providing affordable high-quality medicines for a healthier world. The Company is India's leading ...

Wockhardt, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹1401.45. The stock has experienced fluctuations today, with a low of ...

Wockhardt Limited is a global pharmaceutical and biotechnology company. The company was established in 1967 by Dr. Habil Khorakiwala, who also serves as the Chairman. Wockhardt is headquartered in ...

Wockhardt expects FDA approval for Zaynich by mid-next year, and its US launch in 2027. The company's hope is the drug's large addressable market: The US has 250,000-300,000 patients who could use ...

Wockhardt is planning to exit the US generics business. Meanwhile, US consumers will have to bear the burden of tariffs, NDTV Profit reported. Habil Khorakiwala, chairperson of Wockhardt, said, "There ...

Mumbai: Wockhardt has announced that Wockhardt Bio AG, a subsidiary of the Company, has incorporated a new wholly owned subsidiary in Ireland by the name Wockhardt Antibiotics (Ireland) Limited.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Drugmaker Wockhardt has decided to exit its remaining generics business in the US, for commercial reasons. Over two years ago, the Mumbai-based drugmaker had announced that it was closing its ...

Pharmaceutical company Wockhardt won’t face a significant impact of the global turmoil over US tariffs due to its strong business model, according to the company’s founder and chairman Habil ...

Shares of pharmaceutical company Wockhardt surged over two percent on April 1 after the company announced that its novel antibiotic Zaynich drug was successful in curing a severe drug-resistant ...